Bharat Biotech's Covaxin Approval Requested In US For Children Below 18

US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.

from NDTV News - Topstories https://ift.tt/3bIUCMT
https://ift.tt/eA8V8J https://www.ndtv.com